Realta Investment Advisors Makes New $244,000 Investment in Astera Labs, Inc. (NASDAQ:ALAB)

Realta Investment Advisors bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,655 shares of the company’s stock, valued at approximately $244,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. US Bancorp DE bought a new stake in Astera Labs during the 3rd quarter worth approximately $46,000. Strategic Blueprint LLC raised its stake in Astera Labs by 3.6% during the 3rd quarter. Strategic Blueprint LLC now owns 5,684 shares of the company’s stock worth $298,000 after acquiring an additional 195 shares during the period. Allworth Financial LP raised its stake in Astera Labs by 445.5% during the 3rd quarter. Allworth Financial LP now owns 1,091 shares of the company’s stock worth $57,000 after acquiring an additional 891 shares during the period. Highland Capital Management LLC bought a new stake in Astera Labs during the 3rd quarter worth approximately $1,594,000. Finally, Mount Yale Investment Advisors LLC purchased a new stake in Astera Labs during the 3rd quarter valued at approximately $594,000.

Insider Activity at Astera Labs

In related news, insider Sanjay Gajendra sold 110,000 shares of Astera Labs stock in a transaction dated Friday, October 11th. The stock was sold at an average price of $69.47, for a total value of $7,641,700.00. Following the completion of the sale, the insider now directly owns 835,000 shares in the company, valued at $58,007,450. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, insider Sanjay Gajendra sold 110,000 shares of Astera Labs stock in a transaction dated Friday, October 11th. The stock was sold at an average price of $69.47, for a total value of $7,641,700.00. Following the completion of the sale, the insider now directly owns 835,000 shares in the company, valued at $58,007,450. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Jack R. Lazar sold 2,000 shares of Astera Labs stock in a transaction dated Friday, October 11th. The shares were sold at an average price of $69.95, for a total value of $139,900.00. Following the completion of the transaction, the director now owns 135,000 shares in the company, valued at $9,443,250. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 564,458 shares of company stock worth $31,970,841 over the last three months.

Astera Labs Trading Up 3.5 %

NASDAQ:ALAB opened at $72.65 on Friday. Astera Labs, Inc. has a twelve month low of $36.22 and a twelve month high of $95.21. The stock has a fifty day simple moving average of $54.35 and a 200-day simple moving average of $58.00.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 6th. The company reported $0.13 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.02. The business had revenue of $76.90 million for the quarter, compared to the consensus estimate of $72.41 million. The company’s revenue for the quarter was up 17.8% compared to the same quarter last year. Research analysts forecast that Astera Labs, Inc. will post -0.54 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of research analyst reports. Barclays cut their price objective on shares of Astera Labs from $85.00 to $70.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. Evercore ISI cut their price objective on shares of Astera Labs from $98.00 to $80.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Roth Mkm cut their price objective on shares of Astera Labs from $85.00 to $60.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. JPMorgan Chase & Co. cut their target price on shares of Astera Labs from $95.00 to $70.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. Finally, Stifel Nicolaus cut their target price on shares of Astera Labs from $87.00 to $80.00 and set a “buy” rating for the company in a report on Monday, August 5th. Eleven research analysts have rated the stock with a buy rating, According to MarketBeat.com, Astera Labs currently has a consensus rating of “Buy” and a consensus target price of $73.09.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.